The Bancorp (TBBK) Form 144: 9,841 Shares Planned Sale on NASDAQ

Rhea-AI Filing Summary

The Bancorp Inc. (TBBK) Form 144 notice shows an insider sale of 9,841 common shares acquired as equity compensation on 02/09/2025. The shares are to be sold through Raymond James & Associates on 09/10/2025 on NASDAQ with an aggregate market value reported as $751,070.00. The filing reports 46,070,000 shares outstanding, and notes no securities sold by this person in the past three months. The filer certifies no undisclosed material adverse information and indicates cash payment for the acquisition.

Positive

• Clear disclosure of acquisition date (02/09/2025), acquisition type (equity comp), and planned sale date (09/10/2025).
• Filer certifies there is no undisclosed material adverse information and reports no sales in prior three months.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice of an insider sale; disclosed quantities and timing suggest limited market impact.

The filing reports a planned sale of 9,841 shares obtained as equity compensation on 02/09/2025, to be executed via Raymond James on 09/10/2025. The aggregate value is stated as $751,070 against 46,070,000 shares outstanding, which represents a de minimis percentage of the float based on the provided figures. No sales in the prior three months are reported and the filer affirms there is no undisclosed material information. From a trading-impact perspective this is a routine, pre-clearable disclosure under Rule 144.

Corporate Governance Specialist

TL;DR: Disclosure aligns with Rule 144 formalities; documentation of acquisition date and payment type improves transparency.

The notice specifies acquisition as equity compensation and cash payment on the same acquisition date, which helps confirm the provenance of the shares being sold. The statement that there were no other sales in the prior three months and the signer’s certification about material disclosures are typical governance controls to limit regulatory risk. The document does not include additional governance events or material changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	9841	751070.00	46070000	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/09/2025	Equity Comp	Issuer			9841	02/09/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares is TBBK selling under Form 144?

The filing lists 9,841 shares of common stock to be sold.

When were the shares acquired and how were they paid for?

The shares were acquired on 02/09/2025 as equity compensation and payment is listed as cash on 02/09/2025.

Through which broker and when will the sale occur?

The sale is to be executed through Raymond James & Associates on 09/10/2025 on NASDAQ.

What is the aggregate market value and how many shares are outstanding?

Aggregate market value is reported as $751,070.00 and shares outstanding are listed as 46,070,000.

Did the filer sell other securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.